Genentech's Avastin wins FDA approval to treat yet another cancer

Genentech Inc.'s venerable cancer drug Avastin was approved by federal regulators Friday to treat women with a specific type of ovarian cancer — the first Food and Drug Administration ovarian cancer drug approval in 15 years...